OPDIVOCOMBOMNSCLC-MPM.COM

Last Updated: June 26, 2024

OPDIVOCOMBOMNSCLC-MPM.COM Summary

opdivocombomnsclc-mpm.com has 4 NS records, 1 A records, 0 AAAA records, 2 MX records, and 1 TXT records. Name servers for opdivocombomnsclc-mpm.com are ns3.bms.com, ns1.bms.com, ns2.bms.com, ns4.bms.com. A records for opdivocombomnsclc-mpm.com are 45.60.150.161. MX records that process @opdivocombomnsclc-mpm.com email are loki.bms.com, chimeria.bms.com. We have observed opdivocombomnsclc-mpm.com to have 2 subdomains. A subdomain count of 2 is considered a small digital footprint. The website's description is: "find opdivo® (nivolumab) efficacy information for the treatment of non-small cell lung cancers. please see indications and important safety information."

Search DigitalStakeout ASI to find another asset.

OPDIVOCOMBOMNSCLC-MPM.COM DNS Records

A Records

45.60.150.161

AAAA Records

No DNS AAAA records

TXT Records

opdivocombomnsclc-mpm.com. 600 IN TXT "f3gx7lsks8zh4c551nlv1365j89dphl0"

Search DigitalStakeout ASI to find another asset.

OPDIVOCOMBOMNSCLC-MPM.COM Subdomains

opdivocombomnsclc-mpm.com has 2 subdomains in our inventory.

Hostname IP Address
opdivocombomnsclc-mpm.com 45.60.150.161
smetrics.opdivocombomnsclc-mpm.com 63.140.36.148

Search DigitalStakeout ASI to find another asset.

OPDIVOCOMBOMNSCLC-MPM.COM Website

IP Address

45.60.150.161

Meta Tags

og:type: website

og:url: https://www.opdivohcp.com/efficacy/nsclc

og:title: efficacy data for non-small cell lung cancer (nsclc) | opdivo® (nivolumab)

og:description: find opdivo® (nivolumab) efficacy information for the treatment of non-small cell lung cancers. please see indications and important safety information.

og:image: https://www.opdivohcp.com/content/dam/commercial/us/opdivo-hcp-pan-tumor/en/images/opdivo-logo-n.svg

Search DigitalStakeout ASI to find another asset.

OPDIVOCOMBOMNSCLC-MPM.COM Certificate Trust

No certificate log entry found for opdivocombomnsclc-mpm.com. Please check back at a later time.

Search DigitalStakeout ASI to find another asset.